Growth curves in radio-chemo-immunotherapy of lung cancer
Lenzi, M.
La Radiologia Medica 63(2): 111-120
1977
ISSN/ISBN: 0033-8362 PMID: 877306 Document Number: 111231
Document emailed within 1 workday
Related Documents
Kodama, I.; Aoyagi, K.; Tanaka, T.; Kumegawa, H.; Ohta, J.; Maruiwa, M.; Kofuji, K.; Takeda, J.; Kakegawa, T. 1993: A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(9): 1237-1240Schmähl, D. 1977: Chemo- and immunotherapy in cancer surgery Münchener Medizinische Wochenschrift 119(18): 601-602
Schlag, P.M. 1994: Adjuvant systemic chemo- or immunotherapy of colon cancer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(6): 503-508
Van der Meijden, A.P. 1992: New approaches to intravesical chemo-immunotherapy in superficial bladder cancer Progress in Clinical and Biological Research 378: 95-101
2012: First-line erlotinib inferior to chemo in advanced lung cancer Oncology 26(10): 930-931
Hida, T. 1993: Antigen phenotype of lung cancer and its relation to chemo-radiosensitivity Rinsho Byori. Japanese Journal of Clinical Pathology 41(2): 170-173
Strelkov, R.B. 1967: Effect of neurolytic agents on the activity of sulfur containing radio protectors beta mercapto ethylamine radio protect cystamine radio protect beta aminoiso thiuronium bromide hydro bromide radio protect cysteine radio protect atropine radio protect hexonium radio protect methyl diazil radio protect dimedrol radio protect mouse Radiobiologiya 7(6): 939-940
Takai, D. 2010: Aberrant methylation of circulating DNA for prediction of chemo-sensitivity of non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(2): 189-193
Matthias, M. 1975: Chemo- and immunotherapy of malignant neoplasms Zeitschrift für Arztliche Fortbildung 69(11): 580-584
Scott, M.T. 1977: Chemo-immunotherapy of mouse tumours using cyclophosphamide and C. parvum Developments in Biological Standardization 38: 307-310
Kashimura, S.; Terashima, M.; Soeta, N.; Otani, S.; Hoshino, M.; Kanzaki, N.; Matsuyama, S.; Hoshino, Y.; Kogure, M.; Gotoh, M.; Ogata, T.; Ohto, H. 2004: Experimental study for a combination chemo-immunotherapy using dendritic cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1631-1633
Todorov, D.K.; Silyanovska, K.K.; Maneva, K.M.; Ilarionova, M.V.; Gantchev, G.T.; Getov, C.M. 1987: Chemo- and immunotherapy of an adenovirus-induced transplantable sarcoma in hamsters Neoplasma 34(3): 287-294
Rizvi, N.A. 2017: The use of immunotherapy in the first-line treatment of lung cancer Clinical Advances in Hematology and Oncology: H&o 15(3): 190-192
Hersh, E.M.; Mavligit, G.M.; Gutterman, J.U. 1974: Immunotherapy as related to lung cancer: a review Seminars in Oncology 1(3): 273-278
Meganem, H.; Socianu, R.-M.; Bouchaab, H.; Mederos, N.; Nguyen-Ngoc, T.; Peters, S.; Dolcan, A. 2019: The new management options for lung cancer in the immunotherapy era Revue Medicale Suisse 15(651): 1032-1037
Panettiere, F.J.; Constanzi, J.J. 1979: Advances in the chemotherapy and immunotherapy of lung cancer Texas Medicine 75(2): 95-97
Nikonov, S.D.; Ogirenko, A.P.; Mostovaia, G.V.; Chernykh, E.R.; Khonina, N.A.; Zhdanov, O.A.; Krasova, N.G.; Pavlova, N.G.; Berov, B.S.; Man'ko, G.V.; Grachev, A.V. 2002: Efficiency of locoregional and lymphotropic intermittent chemo-immunotherapy for pulmonary tuberculosis Problemy Tuberkuleza 4: 9-12
Brinkmann, O.A.; Bruns, F.; Prott, F.J.; Hertle, L. 1999: Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC) Anticancer Research 19(2c): 1583-1587
Watanabe, Y.; Shimizu, J.; Oda, M.; Yoshida, M.; Watanabe, S.; Iwa, T. 1991: Clinical significance of immunotherapy for lung cancer--present and future Nihon Geka Gakkai Zasshi 92(9): 1217-1220
Fujisawa, T. 1985: Transfer factor immunotherapy as an adjunct to surgery in lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 68-73